Copyright Reports & Markets. All rights reserved.

Global Nasal Spray Live Attenuated Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nasal Spray Live Attenuated Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Trivalent Nasal Spray Live Attenuated Vaccine
    • 1.3.3 Quadrivalent Nasal Spray Live Attenuated Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nasal Spray Live Attenuated Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals & Clinics
    • 1.4.3 Public Health Organizations
    • 1.4.4 Research Organizations
    • 1.4.5 Others
  • 1.5 Global Nasal Spray Live Attenuated Vaccine Market Size & Forecast
    • 1.5.1 Global Nasal Spray Live Attenuated Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Nasal Spray Live Attenuated Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Nasal Spray Live Attenuated Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Nasal Spray Live Attenuated Vaccine Product and Services
    • 2.1.4 AstraZeneca Nasal Spray Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Sanofi
    • 2.2.1 Sanofi Details
    • 2.2.2 Sanofi Major Business
    • 2.2.3 Sanofi Nasal Spray Live Attenuated Vaccine Product and Services
    • 2.2.4 Sanofi Nasal Spray Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Sanofi Recent Developments/Updates
  • 2.3 CSL
    • 2.3.1 CSL Details
    • 2.3.2 CSL Major Business
    • 2.3.3 CSL Nasal Spray Live Attenuated Vaccine Product and Services
    • 2.3.4 CSL Nasal Spray Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 CSL Recent Developments/Updates
  • 2.4 BioDiem
    • 2.4.1 BioDiem Details
    • 2.4.2 BioDiem Major Business
    • 2.4.3 BioDiem Nasal Spray Live Attenuated Vaccine Product and Services
    • 2.4.4 BioDiem Nasal Spray Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BioDiem Recent Developments/Updates
  • 2.5 SEQIRUS, INC.
    • 2.5.1 SEQIRUS, INC. Details
    • 2.5.2 SEQIRUS, INC. Major Business
    • 2.5.3 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product and Services
    • 2.5.4 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 SEQIRUS, INC. Recent Developments/Updates
  • 2.6 Changchun BCHT Biotechnology Co.
    • 2.6.1 Changchun BCHT Biotechnology Co. Details
    • 2.6.2 Changchun BCHT Biotechnology Co. Major Business
    • 2.6.3 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product and Services
    • 2.6.4 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Changchun BCHT Biotechnology Co. Recent Developments/Updates
  • 2.7 Serum Institute
    • 2.7.1 Serum Institute Details
    • 2.7.2 Serum Institute Major Business
    • 2.7.3 Serum Institute Nasal Spray Live Attenuated Vaccine Product and Services
    • 2.7.4 Serum Institute Nasal Spray Live Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Serum Institute Recent Developments/Updates

3 Competitive Environment: Nasal Spray Live Attenuated Vaccine by Manufacturer

  • 3.1 Global Nasal Spray Live Attenuated Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Nasal Spray Live Attenuated Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Nasal Spray Live Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Nasal Spray Live Attenuated Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Nasal Spray Live Attenuated Vaccine Manufacturer Market Share in 2025
  • 3.5 Nasal Spray Live Attenuated Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Nasal Spray Live Attenuated Vaccine Market: Region Footprint
    • 3.5.2 Nasal Spray Live Attenuated Vaccine Market: Company Product Type Footprint
    • 3.5.3 Nasal Spray Live Attenuated Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nasal Spray Live Attenuated Vaccine Market Size by Region
    • 4.1.1 Global Nasal Spray Live Attenuated Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Nasal Spray Live Attenuated Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Nasal Spray Live Attenuated Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Nasal Spray Live Attenuated Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Nasal Spray Live Attenuated Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Nasal Spray Live Attenuated Vaccine Consumption Value (2021-2032)
  • 4.5 South America Nasal Spray Live Attenuated Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Nasal Spray Live Attenuated Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Nasal Spray Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Nasal Spray Live Attenuated Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Nasal Spray Live Attenuated Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Nasal Spray Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Nasal Spray Live Attenuated Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Nasal Spray Live Attenuated Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Nasal Spray Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Nasal Spray Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Nasal Spray Live Attenuated Vaccine Market Size by Country
    • 7.3.1 North America Nasal Spray Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Nasal Spray Live Attenuated Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Nasal Spray Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Nasal Spray Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Nasal Spray Live Attenuated Vaccine Market Size by Country
    • 8.3.1 Europe Nasal Spray Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Nasal Spray Live Attenuated Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nasal Spray Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Nasal Spray Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Nasal Spray Live Attenuated Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Nasal Spray Live Attenuated Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Nasal Spray Live Attenuated Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Nasal Spray Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Nasal Spray Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Nasal Spray Live Attenuated Vaccine Market Size by Country
    • 10.3.1 South America Nasal Spray Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Nasal Spray Live Attenuated Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Nasal Spray Live Attenuated Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Nasal Spray Live Attenuated Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Nasal Spray Live Attenuated Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Nasal Spray Live Attenuated Vaccine Market Drivers
  • 12.2 Nasal Spray Live Attenuated Vaccine Market Restraints
  • 12.3 Nasal Spray Live Attenuated Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nasal Spray Live Attenuated Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nasal Spray Live Attenuated Vaccine
  • 13.3 Nasal Spray Live Attenuated Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nasal Spray Live Attenuated Vaccine Typical Distributors
  • 14.3 Nasal Spray Live Attenuated Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nasal Spray Live Attenuated Vaccine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Nasal spray live attenuated vaccine is a live attenuated viral vaccine administered by nasal spray for the prevention of infection against specific diseases. This vaccine injects a weakened live virus into the body through the nasal mucosal route, which activates the immune system to produce a protective immune response against the disease.
    This report is a detailed and comprehensive analysis for global Nasal Spray Live Attenuated Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nasal Spray Live Attenuated Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
    Global Nasal Spray Live Attenuated Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
    Global Nasal Spray Live Attenuated Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
    Global Nasal Spray Live Attenuated Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nasal Spray Live Attenuated Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nasal Spray Live Attenuated Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., Changchun BCHT Biotechnology Co., Serum Institute, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nasal Spray Live Attenuated Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Trivalent Nasal Spray Live Attenuated Vaccine
    Quadrivalent Nasal Spray Live Attenuated Vaccine
    Market segment by Application
    Hospitals & Clinics
    Public Health Organizations
    Research Organizations
    Others
    Major players covered
    AstraZeneca
    Sanofi
    CSL
    BioDiem
    SEQIRUS, INC.
    Changchun BCHT Biotechnology Co.
    Serum Institute
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nasal Spray Live Attenuated Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nasal Spray Live Attenuated Vaccine, with price, sales quantity, revenue, and global market share of Nasal Spray Live Attenuated Vaccine from 2021 to 2026.
    Chapter 3, the Nasal Spray Live Attenuated Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nasal Spray Live Attenuated Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nasal Spray Live Attenuated Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nasal Spray Live Attenuated Vaccine.
    Chapter 14 and 15, to describe Nasal Spray Live Attenuated Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now